Funder
Polish National Science Centre
Publisher
Springer Science and Business Media LLC
Reference77 articles.
1. Argemi X, Hansmann Y, Riegel P, Prévost G. Is Staphylococcus lugdunensis significant in clinical samples? J Clin Microbiol. 2017;55(11):3167–74.
2. Argemi X, Riegel P, Lavigne T, Lefebvre N, Grandpré N, Hansmann Y, et al. Implementation of MALDI-TOF MS in routine clinical laboratories improves identification of coagulase negative staphylococci and reveals the pathogenic role of Staphylococcus lugdunensis. J Clin Microbiol. 2015;53(7):2030–6. JCM.00177–15
3. Argemi X, Prévost G, Riegel P, Keller D, Meyer N, Baldeyrou M, et al. VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2017;23:334. e1–334.e8
4. Foster TJ, Geoghegan JA, Ganesh VK, Höök M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2014;12:49–62.
5. Argemi X, Martin V, Loux V, Dahyot S, Lebeurre J, Guffroy A, et al. Whole-genome sequencing of seven strains of Staphylococcus lugdunensis allows identification of mobile genetic elements. Genome Biol Evol. 2017;9
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献